Anthos Therapeutics’ mission is to improve the lives of patients with cardiovascular

Anthos Therapeutics’ mission is to improve the lives of patients with cardiovascular and metabolic diseases by developing and delivering innovative, high impact therapies. The company’s vision is to be a leader in the biopharmaceutical industry, providing groundbreaking treatments that address the complex challenges of CVM diseases. Anthos Therapeutics is focused on developing therapies that are both genetically and pharmacologically validated, ensuring their efficacy and safety in treating CVM diseases:The company is working on therapies that target the underlying mechanisms of thrombosis and hemostasis, aiming to provide safer and more effective treatments for conditions such as venous thrombo embolism (VTE) and arterial thrombosis.Anthos Therapeutics is also exploring innovative approaches to treat heart failure, focusing on therapies that improve cardiac function and patient outcomes.